Company Spokesperson

Life-saving opioid dependency drug Sublocade to be withdrawn from Australian market

US pharmaceutical company Indivior will withdraw its "life-saving" opioid dependency drug Sublocade from the Australian market by December 31, citing commercial reasons. The decision has alarmed doctors and pharmacists, who note Sublocade's effectiveness and patient preference over alternatives like Buvidal. This follows AstraZeneca's recent withdrawal of Zoladex, also due to commercial viability concerns.